FACTFLOW

Wednesday, 12 August 2026 · Global Edition · Updated 11:25 CST

Adeia reiterates $395M-$435M 2026 revenue outlook amid CEO transition plan targeting Q4 successor

Advanced Energy forecasts low-to-mid-20% 2026 revenue growth as it targets over 43% gross margin

Repay outlines 2026 revenue of $340M-$346M and targets ~42% adjusted EBITDA margin as it plans to close KUBRA in Q2 2026

Tactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process matures

ThredUp outlines $351.2M-$356.2M 2026 revenue while holding adjusted EBITDA at ~6.1% amid selective consumer

RB Global expects 2026 GTV growth of 6%-9% while BigIron closing targeted for Q2

Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts

BioMarin outlines $3.825B-$3.925B 2026 revenue outlook driven by Amicus integration and 20% growth target

Firefly forecasts $420M-$450M 2026 revenue as NASA lunar cadence accelerates and Golden Dome work ramps

Gold extends decline as Gulf clashes lift yields and rate expectations

Allison outlines 2026 revenue of $5.575B-$5.925B while targeting $120M annual run rate synergies

GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth

Biodesix raises 2026 revenue outlook to $108M-$114M as it targets sustained adjusted EBITDA profitability

EverQuote outlines Q2 revenue of $185M-$195M while targeting $1B in revenue in 2-3 years

Matson raises full-year 2026 operating income outlook to modestly exceed 2025, driven by post-lunar new year China demand

Prev 1 … 329 330 331 332 333 334 335 … 702 Next